Table of Contents Table of Contents
Previous Page  539 / 1096 Next Page
Information
Show Menu
Previous Page 539 / 1096 Next Page
Page Background

S524

ESTRO 36

_______________________________________________________________________________________________

cylinder applicator (Figure 1b) with 5 catheters. Inter-

dwell distances of 2 and 5 mm were employed and the

experiments performed for source activities between 5

and 10 Ci. The EPID response is proportional to the source

activity so it is possible to obtain the activity by sending

the

source

to

pre-defined

dwell

position.

Results

3D Cartesian coordinates can be obtained with 0.2 mm

accuracy using a single EPID panel. The panel can clearly

identify dwell positions 2 mm apart even with the catheter

at 24 cm distance (Figure 1c) from the panel. Absolute

coordinates can be obtained by adding reference points

(representing the corners of the water phantom) in the

treatment plan that can be related with the position of

the water phantom over the panel during the experiments.

An

in-house

developed software compares all dwell

positions/times against the treatment plan. The software

can also monitor the sequence of the treatment

identifying the afterloader channel connected to each

catheter. Therefore, it is possible to detect catheter

misplacements, swapped transfer tube connections,

wrong dwell times and/or positions and also verify the

source activity.

Conclusion

This work describes an experimental system that can be

implemented in the clinic

providing experimental pre-

treatment verification that is not currently available. This

method provides several advantages when compared

against other dosimeters such as films or MOSFETs as it

combines a 2D dosimeter, which has an online response.

Our system can detect several problems that would be

unnoticed during the treatment if only traditional QA is

performed.

PO-0946 Entropic model for real-time dose

calculation: I-125 prostate brachytherapy application.

G. Birindelli

1

, J.L. Feugeas

1

, B. Dubroca

1

, J. Caron

1,2

, J.

Page

1

, T. Pichard

1

, V. Tikhonchuk

1

, P. Nicolaï

1

1

Centre Lasers Intenses et Applications, Interaction-

Fusion par Confinement Inertiel- Astrophysique,

Talence, France

2

Institut Bergonié Comprehensive Cancer Center,

Department of radiotherapy, Bordeaux, France

Purpose or Objective

This work proposes a completely new Grid Based

Boltzmann Solver (GBBS) conceived for the description of

the transport and energy deposition by energetic particles

for brachytherapy purposes. Its entropic closure and

mathematical formulation allow our code (M

1

) to calculate

the delivered dose with an accuracy comparable to the

Monte Carlo (MC) codes with a computational time that is

reduced to the order of few seconds without any special

processing power requirement.

Material and Methods

The kinetic M

1

model, is based on the spherical harmonic

expansion of the distribution function, solution of the

linear Boltzmann equation. The first two angular moments

equations, combined with the Continuous Slowing Down

Approximation, are closed using the Boltzmann's principle

of entropy maximization. The algorithm computes at the

same time all primary and secondary particles created by

the interactions of the beam with the medium. Thanks to

the implementation of the interaction cross sections for

electrons and photons in the energy range from 1keV up

to 100 MeV, the algorithm can simulate different

treatment techniques such as the external radiotherapy,

brachytherapy or intra-operative radiation therapy.

As a first validation step, a large number of heterogeneity

shapes has been defined for various complex numerical

phantoms both for electron and photon monoenergetic

sources. Dose profiles at different positions have been

measured in water phantoms including inhomogeneity of

bone ( ρ = 1.85 g/cm

3

), lung ( ρ = 0.3 g/cm

3

) and air ( ρ =

10

-3

g/cm

3

). Secondly, taking as reference the Carleton

Laboratory for Radiotherapy Physics Database, different

radioactive seeds have been implemented in the code.

Moreover, several simulations based on CT scan of

prostate cancer have been performed. The M

1

model is

validated with a comparison with a standard, accurate but

time consuming, statistical simulation tools as PENELOPE.

Results

The M1 code is capable of calculating 3D dose distribution

with 1mm

3

voxels without statistical uncertainties in few

seconds instead of several minutes as PENELOPE. Thanks

to its capability to take into account the presence of

inhomogeneities and strong density gradients, the dose

distributions significantly differ from those calculated

with the TG-43 approximations. More in detail: inter-seed

attenuation is treated, the real chemical composition of

the different tissues can be taken into account and the

effects of patient dimensions are considered.

Conclusion

In the comparison with the MC results the excellent

accuracy of the M

1

model is demonstrated. In general, M

1

,

as the MC codes, overcomes the approximations that are

formalised in TG-43 in order to decrease the complexity

of the calculations. Thanks to its reduced computational

time and its accuracy M

1

is a promising candidate to

become a real-time decision support tool for

brachytherapists.

PO-0947 Image-guided brachytherapy with 106Ru eye

plaques for uveal melanomas using post implantation

MRI

G. Heilemann

1

, N. Nesvacil

2

, M. Blaickner

3

, L. Fetty

1

, R.

Dunavoelgyi

4

, D. Georg

2

1

Medical University of Vienna/ AKH Vienna, Department

for Radiotherapy, Vienna, Austria

2

Medical University of Vienna/ AKH Vienna, Department

for Radiotherapy/ Christian Doppler Laboratory for

Medical Radiation Research for Radiation Oncology,

Vienna, Austria

3

Austrian Institute of Technology GmbH, Health and

Environment Department Biomedical Systems, Vienna,

Austria

4

Medical University of Vienna/ AKH Vienna, Department

for Ophthalmology and Optometry, Vienna, Austria

Purpose or Objective

In radiation oncology magnetic-resonance imaging (MRI) is

an important modality for tissue characterization, target

delineation and allows image-guidance due to its high soft

tissue contrast as a tool for better cancer treatment. In

106

Ru-brachytherapy of uveal melanomas MRI is mainly

used for pre-treatment planning scans to assess tumor size

and location. However, post-implantation MR scans yield

additional information on the plaque position in relation

to the target volume and critical structures. Together with